
Moonshot AI targets $2B in annualized revenue as Anthropic alleges a Kimi distillation campaign
The AMW Read
Quantifies Moonshot's open-weight revenue trajectory while layering in Anthropic's specific distillation allegation, sharpening but not overturning the CN open-weight commercialization picture.
Moonshot AI targets $2B in annualized revenue as Anthropic alleges a Kimi distillation campaign
Moonshot AI, the Chinese lab behind the Kimi assistant, is targeting $2 billion in annualized revenue by the end of the year, Bloomberg reported — double the run rate the company reported for August. The goal leans on continued usage of K3, the open-weight model released this summer: OpenRouter data shows K3 models generating roughly 300 billion tokens a day on that platform, even though usage has slipped slightly in recent months. The disclosure lands days after Anthropic publicly accused Moonshot of a long-running distillation campaign, alleging nearly 300,000 requests from Kimi were routed directly to Claude Opus and that more than 23 million responses were collected from Anthropic's models for use in Moonshot's own training.
Even at $2B, Moonshot's revenue would remain far behind OpenAI's reported $40B and Anthropic's $65B, and the company's open model weights mean structurally thinner margins than closed-weight rivals charge through licensing. The numbers show open-weight distribution can still convert into real commercial scale — Kimi's OpenRouter token volume is substantial — but that growth is now paired with a specific, documented allegation that some of the model's quality came from routing traffic through a competitor's frontier model rather than Moonshot's own pipeline, complicating the case that CN open-weight labs match frontier capability purely through independent, low-cost training. AMW's own tracking shows coverage of Moonshot roughly doubling over the past 90 days (41 items versus 25 in the prior period, per the AI Market Watch index, limited to pipeline-ingested sources), consistent with simultaneous IPO buildup and dispute-driven attention.
For enterprises evaluating Kimi or K3 for production workloads, the distillation allegation is now a diligence item with specifics — named request counts and response volumes — not just a reputational headline. For investors tracking Moonshot's pending Hong Kong IPO, the $2B target is the first hard revenue figure to underwrite valuation talk, arriving alongside an unresolved dispute over how the underlying model was actually built.

